← Leaderboards
Philip S Zeitler
University Of Colorado Denver
$21,477,687
Attributed
$37,564,977
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.9M · FY2005–19$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$37,564,977 · 9
By mechanism
U01$37,316,523 · 2
M01$248,454 · 7
Top collaborators
- Kimberly Lee Drews4 shared
- Barbara Halina Braffett1 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- John C Hutton$5,451,482
- Raphael A. Nemenoff$15,000,654
- Dana Dabelea$57,991,262
- Raul Martin Torres$14,543,594
- Marian J. Rewers$53,889,410
Others in their field
Top investigators on “Metformin”
- David M Nathan · Massachusetts Institute Of Technology$131,567,540
- John M Lachin · George Washington University$118,921,924
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Sarah E. Fowler · George Washington University$37,648,866
- Jose A Luchsinger · Columbia University Health Sciences$37,118,016
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
MetforminQuality Of LifeAdolescentDiabetes MellitusClinical TrialsMonitorChildIncidenceResourcesGlycemic ControlPatternPrevalenceAdultComplications Of Diabetes MellitusBody CompositionInsulinHealthcareObesityParticipantDiagnosisYouthBaseLife StyleInsight
Grant awards (20)
TODAY2 Phase 2 (T2P2): Long-Term Post-Intervention Follow-Up$6,400,250
U01 · FY2019 · DK
TODAY2 Phase 2 (T2P2): Long-Term Post-Intervention Follow-Up$7,300,000
U01 · FY2018 · DK
TODAY2 Phase 2 (T2P2): Long-Term Post-Intervention Follow-Up$7,300,000
U01 · FY2017 · DK
TODAY2 Phase 2 (T2P2): Long-Term Post-Intervention Follow-Up$7,930,830
U01 · FY2016 · DK
Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study$3,243,500
U01 · FY2015 · DK
Treatment Alternatives in Pediatric Type 2 Diabetes$756,413
U01 · FY2008 · DK · contact PI
Treatment Alternatives in Pediatric Type 2 Diabetes$729,637
U01 · FY2007 · DK · contact PI
TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH (TODAY)$94,489
M01 · FY2007 · RR · contact PI
NEUROHORMONAL REGULATION OF ENERGY BALANCE AMONG PEDIATRIC BRAIN TUMOR SUBJECTS$6,257
M01 · FY2007 · RR · contact PI
PARENT-CHILD CONFLICT, AUTONOMY AND DIABETES SELF-CARE - TODAY STUDY ANCILLARY$1,109
M01 · FY2007 · RR · contact PI
Treatment Alternatives in Pediatric Type 2 Diabetes$191,820
U01 · FY2006 · DK · contact PI
TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH (TODAY)$103,695
M01 · FY2006 · RR · contact PI
OSTEOPOROSIS IN PEDIATRIC BONE MARROW TRANSPLANT PATIENTS$1,620
M01 · FY2006 · RR · contact PI
Treatment Alternatives in Pediatric Type 2 Diabetes$797,387
U01 · FY2005 · DK
TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH (TODAY)$40,912
M01 · FY2005 · RR
Treatment Alternatives in Pediatric Type 2 Diabetes$709,912
U01 · FY2004 · DK
Osteoporosis in Pediatric Bone Marrow Transplant Patients$372
M01 · FY2004 · RR
Treatment Alternatives in Pediatric Type 2 Diabetes$556,774
U01 · FY2003 · DK
Treatment Alternatives in Pediatric Type 2 Diabetes$900,000
U01 · FY2002 · DK
Treatment Alternatives in Pediatric Type 2 Diabetes$500,000
U01 · FY2001 · DK